Cite
HARVARD Citation
van de Ven, M. et al. (2017). Prophylactic window therapy with the clinical poly(ADP‐ribose) polymerase inhibitor olaparib delays BRCA1‐deficient mammary tumour formation in mice. Journal of pathology. 241 (4), pp. 511-521. [Online].